{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05820672",
            "orgStudyIdInfo": {
                "id": "ASND0037"
            },
            "organization": {
                "fullName": "Ascendis Pharma A/S",
                "class": "INDUSTRY"
            },
            "briefTitle": "A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA",
            "officialTitle": "A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)",
            "acronym": "SkybriGHt",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-us-non-interventional-effectiveness-and-safety-study-of-patients-treated-with-skytrofa"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2033-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2033-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-07",
            "studyFirstSubmitQcDate": "2023-04-18",
            "studyFirstPostDateStruct": {
                "date": "2023-04-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Ascendis Pharma Endocrinology Division A/S",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care",
            "detailedDescription": "Patients will be treated according to routine clinical practice, and no additional visits, examinations or tests will be required beyond those performed as part of routine clinical practice except for COAs."
        },
        "conditionsModule": {
            "conditions": [
                "Growth Hormone Deficiency"
            ],
            "keywords": [
                "Human Growth Hormone",
                "SKYTROFA"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "5 Years",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 900,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patients on SKYTROFA Treatment",
                    "description": "Patients on SKYTROFA Treatment managed in USA with appropriate written Informed Consent",
                    "interventionNames": [
                        "Other: No intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "No intervention",
                    "description": "No intervention",
                    "armGroupLabels": [
                        "Patients on SKYTROFA Treatment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Assess the safety of patients treated with SKYTROFA (Lonapegsomatropin)",
                    "description": "Incidence of Adverse Events and Serious Adverse Events",
                    "timeFrame": "5 years"
                },
                {
                    "measure": "Assess the effectiveness of patients treated with SKYTROFA (Lonapegsomatropin)",
                    "description": "Near adult height (cm)",
                    "timeFrame": "5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Assess clinical outcome assessments (COAs)",
                    "description": "Change in Quality of Life in Short Stature Youth (QoLISSY) scores from baseline through End of Study (QOLISSY scores range on a scale of 0 to 100 with higher scores representing better quality of life. (For both child and parent version))",
                    "timeFrame": "5 years"
                },
                {
                    "measure": "Assess clinical outcome assessments (COAs)",
                    "description": "Change in Treatment Satisfaction Questionnaire for Medicine (TSQM-9) scores from baseline through End of Study (The TSQM-9 domain scores range from 0 to 100 with higher scores representing higher satisfaction on that domain)",
                    "timeFrame": "5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who are on treatment with SKYTROFA (lonapegsomatropin)\n* Patients being clinically managed in USA\n* Patients with an appropriate written informed consent/assent as applicable for the age of the patient\n\nExclusion Criteria:\n\n* Patients participating in any interventional clinical study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "1 Year",
            "maximumAge": "18 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ],
            "studyPopulation": "Patients being treated with SKYTROFA who are associated to selected endocrinology or pediatric clinics across USA.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Isabel Couto",
                    "role": "CONTACT",
                    "phone": "+1 844-442-7236",
                    "email": "Skybright_contact@ascendispharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "Ascendis Pharma Investigational Site",
                    "status": "RECRUITING",
                    "city": "Centennial",
                    "state": "Colorado",
                    "zip": "80112",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.57916,
                        "lon": -104.87692
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "T2633",
                    "name": "Growth Hormone Deficiency",
                    "asFound": "Growth Hormone Deficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3125",
                    "name": "Isolated Growth Hormone Deficiency",
                    "asFound": "Growth Hormone Deficiency",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}